Four PM
How the downregulation of our CB1 receptors may be responsible for the ever-increasing demand for high THC cannabis
Matthew O'BrienCommentShare
NewTopCommunityWhat is Four PM?About
Holding the media to a higher standard when it comes to cannabis
Matthew O'Brien
Feb 24CommentShare
Why Weedmaps, LinkedIn, Clubhouse, Twitter & Leafly are all positioned to benefit from the continued rise of cannabis.
Matthew O'Brien and Daniel Elkind
Feb 22CommentShare
Hexo agrees to purchase struggling Canadian cannabis company Zenabis in an all-stock transaction
Matthew O'Brien
Feb 17CommentShare
A turning point in the Canadian cannabis industry as sales in the legal market surpass the illicit market
Matthew O'Brien and Daniel Elkind
Feb 12CommentShare
How one company's explicit focus on medical cannabis paid off
Matthew O'Brien
Feb 10CommentShare
It seems increasingly likely that the U.S. will legalize cannabis on a federal level.
Matthew O'Brien
Feb 8CommentShare
Cannabis 2.0
Matthew O'Brien
Feb 3Comment 3Share
See all

Four PM


What is Four PM?ArchiveAuthorsMy Account
© 2021 Four PM. See privacy, terms and information collection notice
Publish on Substack